Innovative Blood Pressure Measurement Method Offers Hope for Patients with Limited Arm Access

Researchers have developed a new method for accurately measuring blood pressure at the ankle, aiding those unable to have arm readings and potentially reducing misdiagnoses worldwide.
A groundbreaking approach to measuring blood pressure at the ankle promises to significantly improve diagnostic accuracy for individuals who cannot have their arm blood pressure measured. Developed by researchers at the University of Exeter Medical School, this new method enhances the precision of interpreting ankle blood pressure readings, which are often higher than arm measurements.
The study, published in BMJ Open, analyzed data from over 33,000 participants worldwide, aiming to develop a personalized predictive model that estimates arm blood pressure from ankle readings more reliably than previous techniques. To facilitate practical application, an online calculator has been launched to assist healthcare professionals and patients in interpreting these measurements effectively.
High blood pressure affects over one billion people globally and is a leading risk factor for heart, brain, and kidney diseases. Standard practice involves measuring blood pressure on the arm; however, for people with disabilities, limb loss, or conditions such as stroke, arm measurements may be impossible or unreliable.
Blood pressure readings taken at the ankle can be higher than arm readings, and current guidelines for diagnosis and management are based solely on arm measurements. This discrepancy can lead to misdiagnosis and under-treatment.
Led by Professor Chris Clark, the research highlights that the new method could improve diagnosis accuracy for about 2% more people. Although that may seem small, it translates to approximately 750 fewer misdiagnoses annually in England alone, and tens of thousands worldwide. The study utilized advanced statistical modeling to link arm and ankle blood pressures, enabling better predictions of health risks, such as heart attack likelihood based on ankle readings.
This innovation could also reduce healthcare disparities by providing precise measurements for individuals with upper limb disabilities. Currently, an estimated 10,000 adults in the UK have upper limb loss, and about 75% of stroke survivors experience upper limb dysfunction, making arm blood pressure measurement challenging.
Juliet Bouverie, CEO of the Stroke Association, emphasized the significance of this tool in stroke prevention and management, as high blood pressure is a major contributing factor. Similarly, Professor Kevin Munro noted that this solution supports broader detection and treatment of high blood pressure, especially for those who cannot undergo traditional arm measurements.
Overall, this research offers a promising pathway to improve cardiovascular health assessments globally, ensuring more accurate diagnoses and effective treatment strategies for vulnerable populations.
Source: https://medicalxpress.com/news/2025-06-blood-pressure-lifeline-thousands-people.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Germany's Growing Medical Cannabis Industry Gains Momentum Amid Legal and Market Developments
Germany's medical cannabis industry is experiencing rapid growth driven by legal reforms, innovative companies like Cantourage, and increasing patient demand for safe, lab-tested medicinal marijuana.
Effective Strategies to Reduce Pediatric Vehicular Heatstroke Risks
Recent research underscores the importance of combining multiple safety technologies and measures to effectively prevent pediatric vehicular heatstroke and protect children from this preventable danger.
Groundbreaking Discovery of a Treatable Mesothelioma Variant Emphasizes Early Detection and Genetic Testing
A new, less aggressive form of mesothelioma linked to genetic mutations has been discovered, opening doors for targeted treatments and emphasizing the importance of early detection and genetic screening.
FDA Approves Dupixent for Treatment of Bullous Pemphigoid
The FDA has approved Dupixent for adult patients with bullous pemphigoid, offering a new targeted treatment option based on promising clinical trial results that show improved remission and reduced itch.